TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/12/2025
Voltar para busca
Dado oficial do USPTO
D DATAVANT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
56
Atualização mais recente
19/12/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 35, 42
Data de depósito
13/12/2018
Data de registro
07/04/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/04/2020
Última transação
19/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
77
Localização do titular
US
Examinador
MARTINS, ODETTE
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of stylized lowercase blue "D" inside of a blue hexagon which has a break at the top right. Above the stylized lowercase blue "D" are three blue squares. Below the hexagon image is the wording "DATAVANT" in black text. The mark is displayed on a white background which is not claimed as a feature of the mark.
Titulares e representantes
Titulares
Datavant, Inc.
Roivant Sciences GmbH
Representantes
Vanessa A. Ignacio, Esq. Lowenstein Sandler LLP
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer software for transmittinganalyzing and generating reports; downloadable Computer software for data processing in the field of healthcarebiomedical researchclinical trial data; Downloadable computer software for providinganalyzing and generating reports in the field of healthcarebiomedical researchclinical trial data; Downloadable computer software for data processing; Downloadable computer programs and computer operating systems for the capturecollectionconversionanalysiscommunicationprocessingreceivingrecordingstorage and transmission of dataimages and information; Downloadable computer programs and computer operating systems for the conversionanalysisprocessingstorage and transmission of artificial intelligence; Downloadable artificial intelligence and machine learning software for statistical analysisconsultancy and reporting; Downloadable software for analytics in the field of public healthhealthcarepharmaceuticalsbiotechnologybiomedical research and developmentclinical trials as well as post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; Downloadable software for data linkagediscoveryde-identification used in the fields of healthcarebiomedical researchclinical trial data for the provision of medical servicespublic health services and healthcare services; Downloadable computer software for database integration; Downloadable computer software for creating searchable databases of information and data; Downloadable computer software featuring an electronic computer database for linkingviewingde-identifying healthcare and healthcare related data used in the field of healthcarebiomedical researchclinical trial data; Downloadable computer software for accessing data and information related to healthcare servicespatient medical information and clinical trial data and for controlling and managing data and information related to healthcare servicespatient medical information and clinical trial data; none of the foregoing directly related to video surveillance or video based security apparatus
Classe 35
Advertising; business management; business administration; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; business data analysis and professional business consultancy services regarding statistics for biomedical researchhealthcare institutions and healthcare professionalsbased on artificial intelligence and machine learning; business analysis and statistical analysis of healthcare databiomedical research and clinical trial data; systematization and compilation of data in computer databases; compilation of information into computer databases for research and analysis purposes in the fields of public healthhealthcarebiomedicinebiotechnologypharmaceuticalsclinical trialspost-authorization research for the marketing of medicines and/or commercial post-launching of medicinesepidemiological researchpharmacoepidemiological research and research evaluating epidemiological outcomes; professional business analysisbusiness consultancy and statistical analysis for business purposes in the fields of public healthhealthcarepharmaceuticalsbiotechnologybiomedical research and developmentsclinical trialspost-authorization research for the marketing of medicines and/or commercial post-launching of medicinesepidemiological researchpharmacoepidemiological research and research evaluating epidemiological outcomes
Classe 42
Scientific and technological servicesmedical research and scientific researchchemical analysis in the healthcare and biomedical field; Scientific research; Chemical analysis for industrial purposes; Biomedical research services; Design and development of computer software; Cloud computing featuring software for de-identifyinglinkinganalyzing data used in the field of healthcarebiomedical researchclinical trial data; Scientific data processing analysis services; Pharmaceutical and biomedical research servicesconducting clinical trials for otherspost-authorization research for the marketing of medicines and commercial post-launching of medicinesepidemiological researchpharmacoepidemiological research and research evaluating epidemiological outcomes; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifyinglinkinganalyzing data used in the field of healthcarebiomedical researchclinical trial data regarding analytics in the fields of public healthhealthcarepharmaceuticalsbiomedical research and clinical trial data; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifyinglinkinganalyzing data used in the field of healthcarebiomedical researchclinical trial data regarding information in the fields of public healthhealthcarepharmaceuticalsbiomedical research and clinical trials; Providing temporary use of non-downloadable software applications accessible via a web site for the capturecollectionconversionanalysiscommunicationprocessingreceivingrecordingstorage and transmission of dataimages and information; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifyinglinkinganalyzing data used in the field of healthcarebiomedical researchclinical trial data regarding data in the fields of public healthhealthcarepharmaceuticalsbiomedical researchpatient dataclinical trialspost-authorization research for the marketing of medicines and/or commercial post-launching of medicinesepidemiological research and pharmacoepidemiological research; Providing technological online information in the fields of public healthhealthcarepharmaceuticalspatient databiomedical researchclinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines from a computer database or the Internet; Providing scientific online information online in the fields of public healthhealthcarepharmaceuticalspatient databiomedical researchclinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines from a computer database or the Internet; Providing scientific research information in the field of biomedicineclinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; Scientific analysis in the field of scientific data relating to biomedical research and clinical trials; Research and analysis services in the scientific fields of artificial intelligence and machine learning analytics for biomedical research and healthcare institutions
Publicações
Histórico de despachos e eventos da marca no USPTO.
56 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/12/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
18/12/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
18/12/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/05/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/04/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
29/06/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/09/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/08/2020
FIMP
FINAL DISPOSITION PROCESSED
14/08/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/01/2020
PUBO
PUBLISHED FOR OPPOSITION
21/01/2020
GPNX
NOTIFICATION PROCESSED BY IB
17/01/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/01/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2020
ALIE
ASSIGNED TO LIE
17/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
13/12/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/12/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
13/12/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
13/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
03/12/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/12/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
03/12/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
13/11/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/11/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
13/11/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
13/11/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
31/10/2019
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
16/10/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/10/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/10/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/10/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/10/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/08/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/08/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/08/2019
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
26/07/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/07/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/07/2019
RFNT
REFUSAL PROCESSED BY IB
28/06/2019
CHLD
CHANGE OF OWNER RECEIVED FROM IB
27/06/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/06/2019
RFRR
REFUSAL PROCESSED BY MPU
03/06/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/05/2019
CNRT
NON-FINAL ACTION WRITTEN
11/05/2019
MAFR
APPLICATION FILING RECEIPT MAILED
07/05/2019
DOCK
ASSIGNED TO EXAMINER
03/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/05/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
02/05/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/04/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace D DATAVANT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.